Senior Fellow

Ravishankar Jayadevappa, PhD

  • Research Associate Professor, Medicine, Perelman School of Medicine

Ravishankar Jayadevappa, PhD is a Research Associate Professor at the Perelman School of Medicine at the University of Pennsylvania. He is also a member of the Abramson Cancer Center, a Fellow at the Institute of Aging, and Core Investigator at the CHERP, CMCVAMC. His primary areas of research interests are: urologic outcomes, prostate cancer, bladder cancer, overactive bladder, aging, health services research, health care system, health outcomes, regulatory economics, comparative effectiveness, patient-centered care, and more. In particular, the goal of his research is to analyze the tradeoff between economic efficiency, equity, and quality. This has significant implications for understanding and eliminating health disparities due to race, ethnicity, income, and age. His current research focuses on health services research related to micro/macro level health policy issues of the elderly; epidemiology of urologic diseases; patient-centered care; preference assessment; comparative effectiveness; and cost-effectiveness of medical care.

Several of his ongoing projects are directly related to health services research, especially research related to chronic diseases such as prostate cancer, bladder cancer, obesity, breast cancer and Alzheimer’s. He is the principal and collaborative investigator on several federal and non-federal funded grants. Jayadevappa has primary authorship over 70 peer reviewed papers, and is a journal referee for more than 25 medical journals. He is an editor for Gerontology and Geriatric Medicine, Editorial Board Member of the World Journal of Cardiovascular Disease, Editorial Board Member of Case Reports in Urology, and Editorial Advisory Board Member for Medicine. He is a member of many national and local organizations, including the ASCO, AUA, Society for Medical Decision Making, AcademyHealth, International Society of Pharmacoeconomics and Outcomes Research, and also serves on expert review committees for the NIH, PCORI, AHRQ, DOD, and Denmark Cancer Society. 

Related Content